Medical and Endoscopic Treatment in Peptic Ulcer Bleeding: a National German Survey

Zusammenfassung

Einleitung: Ulzera sind die häufigste Ursache für obere GI-Blutungen. Ziel war die endoskopische und medikamentöse Therapie der Ulkusblutung in deutschen Akutkrankenhäusern zu erheben und mit der medizinischen Forschung zu vergleichen. Methoden: Ein strukturierter Fragebogen wurde 3 / 2004 an 1371 Akutkrankenhäuser versandt, die Patienten mit oberer GI-Blutung versorgen. Der Fragebogen war parallel zu einem Fragebogen gestaltet, mit dem 2001 eine vergleichbare Erhebung in Frankreich durchgeführt wurde. Abgefragt wurden in 44 Einzelpunkten Strukturdaten der Kliniken, Organisation der Notfalltherapie, endoskopische und medikamentöse Behandlung der Ulkusblutung. Alle Fragebogen, die bis 8 / 2004 zurückgesendet wurden, wurden in die Auswertung einbezogen. Ergebnisse: Die Rücklaufquote betrug 49 % (675 / 1371). Die mittlere Bettenzahl der Kliniken betrug im Median 200, zu 49 % waren es Häuser der Grundversorgung. Ein 24-h-Endoskopiedienst wird von 92 % der Kliniken (620 / 675) gewährleistet. In 75 % steht eine Fachschwester als Assistenz zur Verfügung. Fiberendoskope werden nur in 15 % verwendet. Im Median werden 10 ± 12 (0 – 160) Blutungen/Monat davon 6 ± 6 Ulkusblutungen (60 %) behandelt. In 72 % werden GI-Blutungen sofort nach Stabilisierung behandelt, alle jedoch innerhalb von 24 h. Die Forrest-Klassifikation wird in 99 % benutzt, dagegen werden Prognosescores (z. B. Baylor-Rockall) nur in 3 % der Fälle angewendet. Forrest Ia, Ib, IIa, IIb, IIc, III werden in 99, 99, 90, 58, 4 bzw. 2 % als Indikation zur endoskopischen Therapie gesehen. Bevorzugte primäre Therapie ist mit Abstand die Injektion (v. a. Adrenalin 1:10 000) und gefolgt von der Clipapplikation. Im Mittel werden 17 ± 13 ml pro Läsion injiziert. 93 % versuchen im Falle einer Rezidivblutung eine erneute endoskopische Therapie. Eine programmierte Re-Endoskopie wird in 63 % durchgeführt. Zur Säuresuppression werden in 99,6 % PPI verwendet, zu 85 % in 2 × täglich Standarddosis. Oralisiert wird zumeist mit Beginn der Nahrungsaufnahme. Die Indikationsstellung zur Eradikation erfolgt nach rationellen Prinzipien. Schlussfolgerung: Die medikamentöse und endoskopische Therapie der Ulkusblutung hat einen hohen Standard erreicht, obwohl einige Therapiestrategien noch der Verbesserung bedürfen. Größere Kliniken zeigen einen Trend, näher am jeweiligen med. Goldstandard zu behandeln.

Abstract

Objective: Peptic ulcers are the leading cause of upper gastrointestinal (GI) bleeding. The aim of this study was the evaluation of the recent clinical practice in drug therapy and endoscopic treatment of ulcer bleedings in Germany and to compare the results with the medical standard. Methods: A structured questionnaire (cross-sectional study) was sent to 1371 German hospitals that provide an emergency service for upper GI bleeding. The project was designed similar to a nationwide inquiry in France in 2001. Forty-four questions concerning the following topics were asked: hospital organisation, organisation of emergency endoscopy service, endoscopic and drug therapy of ulcer bleeding, endoscopic treatment of variceal bleeding. Return of the questionnaires was closed in August 2004. Results: Response rate was 675 / 1371 (49 %). Mean hospitals size was < 200 beds, 49 % (n = 325) had basic care level. 92 % provided a 24-hour endoscopy service, specialized nurses were available in 75 %. Fiberscopes were used only in 15 %. A mean of 10 ± 12 (range: 0 – 160) bleeding cases/month were treated, 6 ± 6 cases per month (60 %) were ulcer bleedings. Endoscopy was performed in 72 % immediately after stabilization but in all cases within 24 hours. The Forrest classification was used in 99 % whereas prognostic scores were applied only in 3 %. Forrest Ia,/Ib/IIa/IIb/IIc/III ulcers were indications for endoscopic therapy in 99 %/ 99 %/ 90 %/ 58 %/ 4 %/ 2 % respectively. Favoured initial treatment was injection (diluted epinephrine, mean volume 17 ± 13 mL/lesion) followed by clipping. In re-bleedings, 93 % tried endoscopic treatment again. Scheduled re-endoscopy was performed in 63 %. PPI were used in 99.6 %, 85 % administered standard dose twice daily. PPI administration was changed from intravenous to oral with the end of fasting in nearly all hospitals. PPI administration schemes can be improved. Indications for Helicobacter pylori eradication followed rational principles. Conclusion: Medical and endoscopic treatment of bleeding ulcers reached a high standard, although some therapeutic strategies leave room for improvement. Bigger hospitals tend to be closer to the medical standard.

gastrointestinale Blutung - obere gastrointestinale Blutung - Ulcus ventriculi

gastrointestinal bleeding - upper gastrointestinal bleeding - peptic ulcer

References

• 1 Marmo R, Koch M, Cipolletta L. et al . Predictive factors of mortality from nonvariceal upper gastrointestinal hemorrhage: a multicenter study.  Am J Gastroenterol. 2008;  103 1639-1647; quiz 1648
• 2 Leerdam M E. Epidemiology of acute upper gastrointestinal bleeding.  Best Pract Res Clin Gastroenterol. 2008;  22 209-224
• 3 Ohmann van C, Imhof M, Ruppert C. et al . Time-trends in the epidemiology of peptic ulcer bleeding.  Scand J Gastroenterol. 2005;  40 914-920
• 4 Leerdam M E, Vreeburg E M, Rauws E A. et al . Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993 / 1994 and 2000.  Am J Gastroenterol. 2003;  98 1494-1499
• 5 Cook D J, Guyatt G H, Salena B J. et al . Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis.  Gastroenterology. 1992;  102 139-148
• 6 Kahi C J, Jensen D M, Sung J J. et al . Endoscopic therapy versus medical therapy for bleeding peptic ulcer with adherent clot: a meta-analysis.  Gastroenterology. 2005;  129 855-862
• 7 Bardou van M, Toubouti Y, Benhaberou-Brun D. et al . Meta-analysis: proton-pump inhibition in high-risk patients with acute peptic ulcer bleeding.  Aliment Pharmacol Ther. 2005;  21 677-686
• 8 Maiss J, Dumser C, Zopf Y. et al . ”Hemodynamic efficacy” of two endoscopic clip devices used in the treatment of bleeding vessels, tested in an experimental setting using the compact Erlangen Active Simulator for Interventional Endoscopy (compactEASIE) training model.  Endoscopy. 2006;  38 575-580
• 9 Lin H J, Perng C L, Sun I C. et al . Endoscopic haemoclip versus heater probe thermocoagulation plus hypertonic saline-epinephrine injection for peptic ulcer bleeding.  Dig Liver Dis. 2003;  35 898-902
• 10 Lo C C, Hsu P I, Lo G H. et al . Comparison of hemostatic efficacy for epinephrine injection alone and injection combined with hemoclip therapy in treating high-risk bleeding ulcers.  Gastrointest Endosc. 2006;  63 767-773
• 11 Ell C, Hagenmuller F, Schmitt W. et al . Multicenter prospective study of the current status of treatment for bleeding ulcer in Germany.  Dtsch Med Wochenschr. 1995;  120 3-9
• 12 Lesur G, Bour B, Aegerter P. Management of bleeding peptic ulcer in France: a national inquiry.  Gastroenterol Clin Biol. 2005;  29 140-144
• 13 Pazart L. Les enquêtes de pratique. Matillon Y DP L’évaluation médicale: du concept à la pratique Paris; Médecine-Sciences Flammarion 1994: 43-47
• 14 Rockall T A, Logan R F, Devlin H B. et al . Risk assessment after acute upper gastrointestinal haemorrhage.  Gut. 1996;  38 316-321
• 15 Messmann H, Schaller P, Andus T. et al . Effect of programmed endoscopic follow-up examinations on the rebleeding rate of gastric or duodenal peptic ulcers treated by injection therapy: a prospective, randomized controlled trial.  Endoscopy. 1998;  30 583-589
• 16 Barkun A, Bardou M, Marshall J K. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding.  Ann Intern Med. 2003;  139 843-857
• 17 Laine L, McQuaid K R. Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of randomized controlled trials.  Clin Gastroenterol Hepatol. 2009;  7 33-47; quiz 1 – 2
• 18 Leerdam M E, Rauws E A, Geraedts A A. et al . Management in peptic ulcer hemorrhage: a Dutch national inquiry.  Endoscopy. 2000;  32 935-942
• 19 Czernichow van P, Hochain P, Nousbaum J B. et al . Epidemiology and course of acute upper gastro-intestinal haemorrhage in four French geographical areas.  Eur J Gastroenterol Hepatol. 2000;  12 175-181
• 20 Saeed Z A, Ramirez F C, Hepps K S. et al . Prospective validation of the Baylor bleeding score for predicting the likelihood of rebleeding after endoscopic hemostasis of peptic ulcers.  Gastrointest Endosc. 1995;  41 561-565
• 21 Atkinson R J, Hurlstone D P. Usefulness of prognostic indices in upper gastrointestinal bleeding.  Best Pract Res Clin Gastroenterol. 2008;  22 233-242
• 22 Lin H J, Hsieh Y H, Tseng G Y. et al . A prospective, randomized trial of large- versus small-volume endoscopic injection of epinephrine for peptic ulcer bleeding.  Gastrointest Endosc. 2002;  55 615-619
• 23 Maiss J, Hochberger J, Schwab D. Hemoclips: which is the pick of the bunch?.  Gastrointest Endosc. 2008;  67 40-43
• 24 Raju G S, Gajula L. Endoclips for GI endoscopy.  Gastrointest Endosc. 2004;  59 267-279
• 25 Maiss J, Prat F, Wiesnet J. et al . The complementary Erlangen active simulator for interventional endoscopy training is superior to solely clinical education in endoscopic hemostasis – the French training project: a prospective trial.  Eur J Gastroenterol Hepatol. 2006;  18 1217-1225
• 26 Maiss J, Wiesnet J, Proeschel A. et al . Objective benefit of a 1-day training course in endoscopic hemostasis using the ”compactEASIE” endoscopy simulator.  Endoscopy. 2005;  37 552-558
• 27 Marmo R, Rotondano G, Piscopo R. et al . Dual therapy versus monotherapy in the endoscopic treatment of high-risk bleeding ulcers: a meta-analysis of controlled trials.  Am J Gastroenterol. 2007;  102 279-289; quiz 469
• 28 Vergara M, Calvet X, Gisbert J P. Epinephrine injection versus epinephrine injection and a second endoscopic method in high risk bleeding ulcers.  Cochrane Database Syst Rev. 2007;  CD005584
• 29 Hochberger J, Matthes K, Maiss J. et al . Training with the compactEASIE biologic endoscopy simulator significantly improves hemostatic technical skill of gastroenterology fellows: a randomized controlled comparison with clinical endoscopy training alone.  Gastrointest Endosc. 2005;  61 204-215
• 30 Lau J Y, Sung J J, Lam Y H. et al . Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers.  N Engl J Med. 1999;  340 751-756
• 31 Riphaus A, Wehrmann T, Weber B. et al . S3-guidelines – sedation in gastrointestinal endoscopy.  Z Gastroenterol. 2008;  46 1298-330
• 32 Lau J Y, Sung J J, Lee K K. et al . Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.  N Engl J Med. 2000;  343 310-316
• 33 Brunner G, Luna P, Hartmann M. et al . Optimizing the intragastric pH as a supportive therapy in upper GI bleeding.  Yale J Biol Med. 1996;  69 225-231
• 34 Laterre P F, Horsmans Y. Intravenous omeprazole in critically ill patients: a randomized, crossover study comparing 40 with 80 mg plus 8mg/hour on intragastric pH.  Crit Care Med. 2001;  29 1931-1935
• 35 Rensburg C J, Hartmann van M, Thorpe A. et al . Intragastric pH during continuous infusion with pantoprazole in patients with bleeding peptic ulcer.  Am J Gastroenterol. 2003;  98 2635-2641
• 36 Alsabah S, Barkun A, Herba K. et al . The cost-effectiveness of continuous infusion intravenous proton pump inhibitor (IV-PPI) administered prior to endoscopy in the treatmet of patients presenting with suspected upper GI-bleeding (UGIB).  Gut. 2007;  56 A304
• 37 Rokkas T, Karameris A, Mavrogeorgis A. et al . Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease.  Gastrointest Endosc. 1995;  41 1-4
• 38 Vergara M, Casellas F, Saperas E. et al . Helicobacter pylori eradication prevents recurrence from peptic ulcer haemorrhage.  Eur J Gastroenterol Hepatol. 2000;  12 733-737
• 39 Schilling D, Demel A, Nusse T. et al . Helicobacter pylori infection does not affect the early rebleeding rate in patients with peptic ulcer bleeding after successful endoscopic hemostasis: a prospective single-center trial.  Endoscopy. 2003;  35 393-396
• 40 Schilling D, Demel A, Adamek H E. et al . A negative rapid urease test is unreliable for exclusion of Helicobacter pylori infection during acute phase of ulcer bleeding. A prospective case control study.  Dig Liver Dis. 2003;  35 217-221
• 41 Fischbach W, Malfertheiner P, Hoffmann J C. et al . S3-guideline ”Helicobacter pylori and gastroduodenal ulcer disease”.  Z Gastroenterol. 2009;  47 68-102